A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
Public ClinicalTrials.gov record NCT03277690. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Study identification
- NCT ID
- NCT03277690
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Cortendo AB
- Industry
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Interventions
- Levoketoconazole Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 25, 2017
- Primary completion
- Jun 29, 2020
- Completion
- Aug 30, 2020
- Last update posted
- Nov 7, 2022
2017 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Keck Medical Center University of Southern California HCII, Internal Medicine - Keck Hospital | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center, Cedars-Sinai Pituitary Center | Los Angeles | California | 90048 | — |
| UCLA School of Medicine, Medicine/Endocrinology Department | Los Angeles | California | 90095 | — |
| The Center for Diabetes and Endocrine Care | Fort Lauderdale | Florida | 33312 | — |
| Emory University, Neurosurgery | Atlanta | Georgia | 30322 | — |
| Northwestern University, Medicine - Endocrinology | Chicago | Illinois | 60611 | — |
| Johns Hopkins University, Endocrinology Department | Baltimore | Maryland | 21287 | — |
| University of Michigan, Comprehensive Endocrine Research, Internal Medicine - MEND | Ann Arbor | Michigan | 48109 | — |
| Washington University School of Medicine, Endocrinology | St Louis | Missouri | 63110 | — |
| Columbia University, College of P&S Medicine/Neuro-endocrine Unit | New York | New York | 10032 | — |
| Memorial Sloan Kettering Cancer Center, Endocrinology | New York | New York | 10065 | — |
| Oregon Health & Science University, Neurological Surgery | Portland | Oregon | 97239 | — |
| Allegheny Neuroendocrinology Center, West Penn Allegheny Health System | Pittsburgh | Pennsylvania | 15212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03277690, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03277690 live on ClinicalTrials.gov.